Maximus Review: Flat-Rate Pricing Across Every Dose And the Best Compounding Disclosure We've Seen

What Is Maximus?

Maximus is a telehealth health-optimization platform rather than a dedicated weight-loss company. Alongside GLP-1s it runs protocols for testosterone, growth hormone peptides, mood and stress, blood flow, hair growth, prescription multivitamins, and comprehensive lab testing of up to 146 markers. The company states it has served 50,000+ men and women.

Its GLP-1 line is unusually complete. On the compounded side it offers semaglutide and tirzepatide; on the brand side it carries Foundayo tablets, Wegovy tablets, Wegovy pens, Zepbound, Ozempic and Mounjaro. Maximus explicitly tells patients they can switch between the compounded and brand-name paths as their needs change, with both supervised by Maximus providers.

Two features set it apart from the rest of the field, and both concern things other providers quietly leave unstated. First, pricing is flat-rate across dose tiers — your cost does not climb as you titrate. Second, Maximus discloses that it uses only the base form of semaglutide and tirzepatide, and explains why that matters. We will come back to both, because they are the reasons this review scores as highly as it does.

Medications Offered & Pricing

Note a wrinkle worth asking about: the product cards advertise compounded semaglutide from $116 and tirzepatide from $198 per 28-day supply, while Maximus's own compounded-vs-brand comparison states compounded cost as '$149.99-$249.99 per month, out of pocket.' The lower figures appear to reflect longer prepaid plans. Maximus also advertises $100 off the first month of medication for new clients purchasing a 12-month plan. For brand-name products the comparison table states 'From $499 per month. Insurance and savings cards may apply,' which is higher than several of the individual brand card prices — confirm your actual rate at checkout.

Brand-Name or Compounded?

Maximus sells both, and is direct about the distinction. Its comparison table lays out the trade-off explicitly: compounded medications are 'Prepared by licensed US compounding pharmacies,' cost '$149.99-$249.99 per month, out of pocket,' require no insurance, offer a dose 'tailored to you' in vial-and-syringe format, and are 'Reliably in stock through our pharmacy partner.' Brand-name products are 'FDA-approved and manufactured by Novo Nordisk or Eli Lilly,' cost 'From $499 per month,' come in fixed-dose pre-filled pens, and are 'Subject to manufacturer shortages from time to time.'

The site repeats, in capitals, that 'COMPOUNDED MEDICATIONS ARE NOT FDA-APPROVED FOR SAFETY, EFFICACY, OR QUALITY.' That is the correct disclosure and Maximus does not bury it.

Then it goes considerably further than any other provider we have reviewed. Asked whether its products are compounded with base form or salt form, Maximus answers: it uses only the base form of semaglutide and tirzepatide, and states that some pharmacies use salt forms such as 'Semaglutide Sodium' or 'Semaglutide Acetate,' which 'are different chemicals, are not equivalent, and have not been tested for safety or effectiveness,' adding that 'Using salt-form compounds may be unsafe or ineffective.'

This is a genuinely significant disclosure. Salt-form semaglutide has been a recurring concern in the compounded GLP-1 market, and it is the kind of detail that determines whether you are getting the molecule studied in the trials or a related chemical that was not. Almost no direct-to-consumer provider addresses it at all. That Maximus raises it unprompted, and answers plainly, tells you something about how the operation is run.

The Consultation Process

Eligibility

• •Maximus states GLP-1 treatment may be appropriate if you are trying to lose weight, reduce appetite, improve blood sugar control, or support long-term metabolic health.
• •A Maximus doctor reviews your medical history and determines whether tirzepatide or semaglutide is safe and appropriate — you do not self-select.
• •If you are not approved for treatment, Maximus states you receive a full refund minus the cost of the doctor consultation.
• •Available nationwide except Alabama, Mississippi and Louisiana.
• •Available to both men and women, despite the platform's broader men's-health positioning.
• •Maximus publishes the standard boxed-warning contraindication: GLP-1s are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Free expedited shipping, delivered in discreet, unmarked packaging. Maximus lists free and discreet shipping as an included feature on both compounded products.

• •Flat-rate monthly plans including access to all dose tiers
• •Custom dosing with ongoing provider adjustments
• •Message providers anytime with no appointments required
• •US-based board-certified medical providers
• •Free expedited, discreet shipping
• •Ability to switch between compounded and brand-name medication
• •Combinable with other Maximus protocols after contraindication review
• •Optional comprehensive lab testing up to 146 markers

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Maximus May Be Best For

• •Patients who expect to titrate to a high maintenance dose and want price certainty the whole way
• •Anyone who cares about compounding quality and wants a provider that will answer the base-form question
• •Patients who want the option to move between compounded and brand-name medication without switching providers
• •People wanting to pay with an HSA or FSA card directly at checkout
• •Patients already interested in testosterone, peptides or lab testing who want one platform
• •Shoppers comparing brand-name GLP-1 cash prices across several products in one place

Limitations

• •The pricing presentation is the weakest part of an otherwise strong offering. Three different figures describe compounded cost depending on where you look, and the brand-name numbers do not reconcile with the comparison table. Get your actual rate confirmed in writing.
• •A promoted 12-month plan with no published cancellation policy is a combination that deserves a direct question before you commit.
• •The consultation fee is non-refundable if you are declined, and Maximus does not publish what it costs — so the downside of being turned down is unquantifiable in advance.
• •Residents of Alabama, Mississippi and Louisiana cannot use the Weight Loss Protocol at all.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Maximus is the strongest provider we have reviewed on the dimensions that are hardest to shop for. Flat-rate pricing across all dose tiers removes the single biggest hidden cost in GLP-1 therapy, and the base-form compounding disclosure answers a question most patients do not know to ask and most providers would rather not be asked. Add HSA/FSA acceptance at checkout, published state exclusions, a refund commitment if you are declined, and an unusually thorough side-effect and boxed-warning section, and you have an operation that is disclosing well beyond the market norm.

The medication range reinforces that. Six brand-name products with published cash prices alongside two compounded options, with an explicit invitation to switch between the two paths, means Maximus can serve you whether your circumstances favour FDA-approved medication or the cheaper compounded route.

What keeps this from a higher score is pricing presentation. Compounded cost appears as $116/$198 per 28-day supply on the product cards and as $149.99–$249.99 per month in the comparison table, and the brand-name 'From $499 per month' line does not reconcile with brand cards starting at $199.99. Combine that with a promoted 12-month plan and no published cancellation policy, and there is real work for the buyer to do before signing. Do that work — get your rate, your plan length and your cancellation terms in writing — and Maximus is among the best options in this market.